Codiak BioSciences, Inc. reports results for the quarter ended in March - Earnings Summary

Codiak BioSciences,.

06/05/2022 05:55

* Codiak BioSciences, Inc.  CDAK.OQ  reported a quarterly
adjusted
loss of 36 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 89 cents per share.
    * Revenue fell 3.7% to $12.70 million from a year ago; 
analysts
expected $4.20 million. 
    * Codiak BioSciences, Inc.'s reported EPS for the quarter
was a
loss of 36 cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Codiak BioSciences, Inc. shares had fallen by 50.7% this
quarter and lost 72.3% so far this year.
    * The company reported a quarterly loss of $8.03 million.
    * Wall Street's median 12-month price target for Codiak
BioSciences, Inc. is $21.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 6 at 04:55 a.m.  ​All
figures in US dollars unless otherwise stated